Lv11
84 积分 2024-04-09 加入
Functional patient-derived organoid screenings identify MCLA-158 as a therapeutic EGFR × LGR5 bispecific antibody with efficacy in epithelial tumors
5小时前
待确认
GPCR drug discovery: new agents, targets and indications
2个月前
已完结
Frameworks for transformational breakthroughs in RNA-based medicines
6个月前
已完结
NaV1.8 inhibitor poised to provide opioid-free pain relief
6个月前
已关闭
Ambroxol, a Nav1.8-preferring Na+ channel blocker, effectively suppresses pain symptoms in animal models of chronic, neuropathic and inflammatory pain
8个月前
已完结
Drug discovery targeting Nav1.8: Structural insights and therapeutic potential
8个月前
已完结
Exploring the therapeutic utility of the factor XIa inhibitor asundexian
8个月前
已完结
Conotoxins targeting voltage-gated sodium ion channels
8个月前
已完结
Structural biology and molecular pharmacology of voltage-gated ion channels
9个月前
已完结
Chronic pain: an update on burden, best practices, and new advances
9个月前
已完结
皖公网安备34019202002308
